South Korea · Delayed Price · Currency is KRW Sewoon Medical Statistics
Total Valuation
Sewoon Medical has a market cap or net worth of KRW 104.18 billion. The enterprise value is 9.21 billion.
| Market Cap | 104.18B |
| Enterprise Value | 9.21B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Sewoon Medical has 42.18 million shares outstanding. The number of shares has decreased by -2.14% in one year.
| Current Share Class | 42.18M |
| Shares Outstanding | 42.18M |
| Shares Change (YoY) | -2.14% |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | 54.81% |
| Owned by Institutions (%) | 0.02% |
| Float | 19.06M |
Valuation Ratios
The trailing PE ratio is 7.50.
| PE Ratio | 7.50 |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | 7.29 |
| P/OCF Ratio | 6.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.52, with an EV/FCF ratio of 0.64.
| EV / Earnings | 0.66 |
| EV / Sales | 0.14 |
| EV / EBITDA | 0.52 |
| EV / EBIT | 0.64 |
| EV / FCF | 0.64 |
Financial Position
The company has a current ratio of 16.78, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.78 |
| Quick Ratio | 14.23 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.08 |
| Interest Coverage | 459.91 |
Financial Efficiency
Return on equity (ROE) is 9.41% and return on invested capital (ROIC) is 19.47%.
| Return on Equity (ROE) | 9.41% |
| Return on Assets (ROA) | 5.53% |
| Return on Invested Capital (ROIC) | 19.47% |
| Return on Capital Employed (ROCE) | 8.90% |
| Weighted Average Cost of Capital (WACC) | 6.56% |
| Revenue Per Employee | 382.35M |
| Profits Per Employee | 79.87M |
| Employee Count | 172 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.37 |
Taxes
In the past 12 months, Sewoon Medical has paid 3.47 billion in taxes.
| Income Tax | 3.47B |
| Effective Tax Rate | 19.29% |
Stock Price Statistics
The stock price has decreased by -7.07% in the last 52 weeks. The beta is 0.43, so Sewoon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -7.07% |
| 50-Day Moving Average | 2,320.40 |
| 200-Day Moving Average | 2,453.13 |
| Relative Strength Index (RSI) | 60.34 |
| Average Volume (20 Days) | 424,436 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sewoon Medical had revenue of KRW 66.53 billion and earned 13.90 billion in profits. Earnings per share was 329.21.
| Revenue | 66.53B |
| Gross Profit | 25.24B |
| Operating Income | 14.33B |
| Pretax Income | 17.97B |
| Net Income | 13.90B |
| EBITDA | 17.60B |
| EBIT | 14.33B |
| Earnings Per Share (EPS) | 329.21 |
Balance Sheet
The company has 99.64 billion in cash and 1.13 billion in debt, with a net cash position of 98.51 billion or 2,335.74 per share.
| Cash & Cash Equivalents | 99.64B |
| Total Debt | 1.13B |
| Net Cash | 98.51B |
| Net Cash Per Share | 2,335.74 |
| Equity (Book Value) | 160.14B |
| Book Value Per Share | 3,712.89 |
| Working Capital | 125.33B |
Cash Flow
In the last 12 months, operating cash flow was 15.92 billion and capital expenditures -1.63 billion, giving a free cash flow of 14.29 billion.
| Operating Cash Flow | 15.92B |
| Capital Expenditures | -1.63B |
| Depreciation & Amortization | 3.27B |
| Net Borrowing | -266.83M |
| Free Cash Flow | 14.29B |
| FCF Per Share | 338.92 |
Margins
Gross margin is 37.93%, with operating and profit margins of 21.54% and 20.89%.
| Gross Margin | 37.93% |
| Operating Margin | 21.54% |
| Pretax Margin | 27.01% |
| Profit Margin | 20.89% |
| EBITDA Margin | 26.46% |
| EBIT Margin | 21.54% |
| FCF Margin | 21.49% |
Dividends & Yields
This stock pays an annual dividend of 70.00, which amounts to a dividend yield of 2.88%.
| Dividend Per Share | 70.00 |
| Dividend Yield | 2.88% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 21.24% |
| Buyback Yield | 2.14% |
| Shareholder Yield | 5.02% |
| Earnings Yield | 13.34% |
| FCF Yield | 13.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 24, 2009. It was a forward split with a ratio of 2.
| Last Split Date | Sep 24, 2009 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Sewoon Medical has an Altman Z-Score of 10.26 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.26 |
| Piotroski F-Score | 6 |